Clinical Cancer Drugs (CCD)

Clinical Cancer Drugs is a peer-reviewed international journal dedicated to the advancement of research on anti-cancer therapeutics, spanning from preclinical drug discovery to clinical application. The journal provides a platform for original research articles, review papers, short communications, and clinical trial reports, focusing on innovative strategies for the treatment of diverse malignancies. Its scope includes the design, synthesis, and evaluation of novel chemical and biological agents, mechanisms of action, pharmacokinetics, pharmacodynamics, and toxicity profiles. The journal emphasizes translational research that bridges laboratory findings with clinical implementation, enabling the development of safer and more effective therapies. Key areas of interest include targeted therapies, immunotherapy, chemotherapy, combination treatments, and personalized medicine approaches. Clinical Cancer Drugs also covers the design, conduct, and analysis of clinical trials (Phase I–IV), post-marketing surveillance, and pharmacovigilance, providing insight into real-world efficacy and safety of cancer therapeutics. By integrating multidisciplinary research from oncology, medicinal chemistry, pharmacology, and molecular biology, the journal fosters collaboration across academia, industry, and clinical practice. Serving as a valuable resource for oncologists, pharmacologists, medicinal chemists, and researchers, Clinical Cancer Drugs contributes to the global effort to advance cancer treatment, improve patient outcomes, and accelerate the development of innovative therapies for malignant diseases.

Clinical Cancer Drugs (CCD) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology and clinical cancer pharmacology, Cancer drug development and testing, Design and analysis of cancer clinical trials, Pre‑clinical research on anti‑cancer agents, Translational medicine bridging laboratory and patient care , Online or Print , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2212-697X, E-ISSN: 2212-6988, Established: 2014,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE